Literature DB >> 2706090

Erythrocyte adducin differential properties in the normotensive and hypertensive rats of the Milan strain. Characterization of spleen adducin m-RNA.

S Salardi1, B Saccardo, G Borsani, R Modica, M Ferrandi, M G Tripodi, M Soria, P Ferrari, F E Baralle, A Sidoli.   

Abstract

Previous studies have shown that erythrocytes from the Milan hypertensive strain of rats (MHS) differ from erythrocytes from the control normotensive strain (MNS). These differences are determined within the stem cells, are genetically associated with the development of hypertension, and are similar to those found between the tubular cells of the two strains. Moreover they seem to be dependent upon the presence of the membrane skeleton proteins. In this paper we describe our studies aimed at identifying some precise protein difference between the membrane skeletons of the two strains, which may cause the cellular differences described above. Milan hypertensive strain and MNS rats were immunized with ghost or membrane skeleton extracts prepared from the other or their own strains. Only MHS rats immunized with MNS ghost or membrane skeleton extracts produced an antibody against a 105 KD protein in about 95% of the animals. This protein has been identified with the recently described cytoskeletal protein adducin on the following bases: the protein binds calmodulin (CaM) and protein kinase C (PKc) in a Ca2+ dependent way. It also binds phosphatidylserine, is the substrate of exogenous PKc, and finally it is purified by high salt extraction of Triton-X100 insoluble erythrocyte cytoskeletons followed by affinity chromatography on CaM-sepharose. Using this antibody the isolation from a mouse spleen library, the characterization and sequencing of a partial cDNA clone coding for this protein has been carried out. In conclusion adducin may be considered a very useful tool to test the hypothesis that the cellular differences between MHS and MNS may be caused by a difference in a membrane skeleton protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706090     DOI: 10.1093/ajh/2.4.229

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

Review 1.  Personalized Therapy of Hypertension: the Past and the Future.

Authors:  Paolo Manunta; Mara Ferrandi; Daniele Cusi; Patrizia Ferrari; Jan Staessen; Giuseppe Bianchi
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport.

Authors:  G Tripodi; F Valtorta; L Torielli; E Chieregatti; S Salardi; L Trusolino; A Menegon; P Ferrari; P C Marchisio; G Bianchi
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 3.  The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.

Authors:  Ezekiel Gonzalez-Fernandez; Letao Fan; Shaoxun Wang; Yedan Liu; Wenjun Gao; Kirby N Thomas; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2021-12-03       Impact factor: 3.107

4.  Two point mutations within the adducin genes are involved in blood pressure variation.

Authors:  G Bianchi; G Tripodi; G Casari; S Salardi; B R Barber; R Garcia; P Leoni; L Torielli; D Cusi; M Ferrandi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Calmodulin-binding domain of recombinant erythrocyte beta-adducin.

Authors:  D A Scaramuzzino; J S Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 6.  Genetic models of arterial hypertension--role of tubular ion transport.

Authors:  D Cusi; M L Melzi; C Barlassina; F Sereni; G Bianchi
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

Review 7.  Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.

Authors:  Piero Ruggenenti; Paola Bettinaglio; Franck Pinares; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-11       Impact factor: 8.237

8.  Primary structure and domain organization of human alpha and beta adducin.

Authors:  R Joshi; D M Gilligan; E Otto; T McLaughlin; V Bennett
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.